Professor David Price
Chair of Primary Care Respiratory Med
- About
-
- Email Address
- d.price@abdn.ac.uk
- Telephone Number
- +44 (0)1224 437237
- School/Department
- School of Medicine, Medical Sciences and Nutrition
- Publications
-
Page 7 of 35 Results 151 to 175 of 858
Correspondence to Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus
Allergy, vol. 77, no. 8, pp. 2571-2573Contributions to Journals: Letters- [ONLINE] DOI: https://doi.org/10.1111/all.15281
- [ONLINE] View publication in Scopus
COPD Population in US Primary Care: Data From the Optimum Patient Care DARTNet Research Database and the Advancing the Patient Experience in COPD Registry
Annals of Family Medicine, vol. 20, no. 4, pp. 319-327Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1370/afm.2829
Oral corticosteroid (OCS) risk predictor for Type II Diabetes in asthma
European Respiratory Society (ERS) International Congress.Contributions to Conferences: AbstractsA Response to: Letter to the Editor Regarding “Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab”
Advances in Therapy, vol. 39, no. 8, pp. 3862-3865Contributions to Journals: LettersPersistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
Aspen Allergy Conference – 40th MeetingContributions to Conferences: AbstractsPersistent OCS reduction regardless of starting OCS dose in patients with severe, OCS-dependent asthma treated with dupilumab: LIBERTY ASTHMA TRAVERSE study
15º Congreso ALAT 2022Contributions to Conferences: AbstractsCharacterisation of the Australian adult population living with asthma: Severe exacerbation frequency, long-term OCS use and adverse effects.
Pragmatic and Observational Research, vol. 2022, pp. 43-58Contributions to Journals: ArticlesHealthcare resource utilisation associated with intermittent oral corticosteroid use in asthma
EAACI HYBRID CONGRESS 2022Contributions to Conferences: AbstractsBiologics in severe asthma: the role of real-world evidence from registries
European Respiratory Review, vol. 31, no. 164, 210278Contributions to Journals: ArticlesPersistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
2022 AANP National ConferenceContributions to Conferences: PostersLet’s improve COPD prognosis: a practical tool for primary care providers to identify the frequency and follow-up of COPD lung attacks
Dutch Lung Congress 2022Contributions to Conferences: AbstractsReply to: Cause or consequence?
European Respiratory Journal, vol. 59, no. 6, 2200103Contributions to Journals: Comments and DebatesReducing asthma attacks in children using exhaled nitric oxide (RAACENO) as a biomarker to inform treatment strategy: a multicentre, parallel, randomised, controlled, phase 3 trial
The Lancet. Respiratory medicine, vol. 10, no. 6, pp. 584-592Contributions to Journals: ArticlesReducción persistente de corticosteroides orales independientemente de la dosis basal, en pacientes con asma córtico-dependiente tratados con dupilumab: Estudio Liberty Asthma-Traverse
55 Congreso Separ, pp. 75Contributions to Journals: AbstractsPersistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
The 35th annual
Eastern Allergy Conference, pp. S9Contributions to Conferences: Abstracts- [ONLINE] Eastern Allergy Conference
- [ONLINE] Conference Abstracts
Quality Standard Position Statements for Health System Policy Changes in Diagnosis and Management of COPD: A Global Perspective
Advances in Therapy, vol. 39, pp. 2302–2322Contributions to Journals: ArticlesTreatment guided by fractional exhaled nitric oxide in addition to standard care in 6- to 15-year-olds with asthma: the RAACENO RCT
Efficacy and Mechanism Evaluation, vol. 9, no. 4Contributions to Journals: ArticlesFactors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers
npj Primary Care Respiratory Medicine, vol. 32, no. 1, 18Contributions to Journals: ArticlesEvaluation of critical inhalation technique errors in patients with COPD on Dry Powder Inhaler maintenance therapy based on their association with health status: findings from the PIFotal study.
IPCRG 2022Contributions to Conferences: Abstracts- [ONLINE] https://www.ipcrg.org/13436
Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study
European Respiratory Journal, vol. 59, no. 5Contributions to Journals: ArticlesSuboptimal peak inspiratory flow and inhalation technique errors are associated with higher COPD-relateD healthcare costs: results from the PIFotal COPD study
IPCRG 2022Contributions to Conferences: Abstracts- [ONLINE] https://www.ipcrg.org/13437
The burden of intermittent oral corticosteroid use in asthma
IPCRG 2022Contributions to Conferences: Abstracts- [ONLINE] https://www.ipcrg.org/13443
Adverse Outcomes Post-initiation of Systemic Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease: A Long-term Observational UK-based Study
ATS 2022Contributions to Journals: AbstractsClinical Remission in Severe Asthma: A Pooled Post hoc Analysis of the Patient Journey with Benralizumab
Advances in Therapy, vol. 39, no. 5, pp. 2065–2084Contributions to Journals: ArticlesImpact of initiating biologics in patients with severe asthma and on long-term oral corticosteroids or rescue steroids (GLITTER)
ATS 2022, D102Contributions to Journals: Abstracts